Shenzhen Weiguang Biological Products Co., Ltd.

SZSE:002880.SZ

33.35 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2024202320222021202020192018201720162015201420132012
Revenue 1,203.1921,048.503667.931907.435904.565821.469687.949623.39566.137500.944452.773355.21300.066
Cost of Revenue 699.325615.259427.024536.523568.218506.133414.328347.175297.838268.009252.028179.89154.997
Gross Profit 503.867433.244240.907370.912336.346315.336273.622276.215268.298232.936200.745175.32145.07
Gross Profit Ratio 0.4190.4130.3610.4090.3720.3840.3980.4430.4740.4650.4430.4940.483
Reseach & Development Expenses 49.05355.76935.86647.58645.09740.16523.70225.62624.77419.77913.77915.46911.936
General & Administrative Expenses 77.8924.68218.01721.1727.99824.69718.05418.71617.10613.98512.10647.30542.988
Selling & Marketing Expenses 17.8240.88527.25423.78519.69124.01924.01214.35312.84512.1611.30311.92211.405
SG&A 95.7165.56645.27244.95547.68948.71642.06633.06929.95126.14523.40859.22754.393
Other Expenses 62.48166.13442.641.3331.54824.4431.3510.50128.33531.10231.3911.0044.448
Operating Expenses 207.244185.935123.738133.87124.333113.32488.03883.71782.3369.61159.08262.50858.543
Operating Income 296.624247.309138.167241.741220.645199.144182178.838168.557139.09111.1193.1779.167
Operating Income Ratio 0.2470.2360.2070.2660.2440.2420.2650.2870.2980.2780.2450.2620.264
Total Other Income Expenses Net 0.112-1.854-0.85-0.566-1.604-0.85-0.1771.946-6.43-17.631-17.734-8.559-3.454
Income Before Tax 296.735245.455137.317241.174219.041198.293181.823180.784179.477145.645117.847104.17483.206
Income Before Tax Ratio 0.2470.2340.2060.2660.2420.2410.2640.290.3170.2910.260.2930.277
Income Tax Expense 42.77827.9116.19736.18229.45627.14225.18626.03526.2520.7917.30515.29311.76
Net Income 253.516218.651117.518205.437190.399171.345156.637154.749153.227124.855100.54288.88171.445
Net Income Ratio 0.2110.2090.1760.2260.210.2090.2280.2480.2710.2490.2220.250.238
EPS 1.120.960.520.910.840.760.690.780.90.730.590.520.42
EPS Diluted 1.120.960.520.910.840.760.690.780.90.730.590.520.42
EBITDA 436.939350.212207.182301.469266.7238.637227.554232.473237.678210.489181.863142.529102.244
EBITDA Ratio 0.3630.3340.310.3320.2950.290.3310.3730.420.420.4020.4010.341